Literature DB >> 2419816

Neovascular glaucoma after helium ion irradiation for uveal melanoma.

M K Kim, D H Char, J L Castro, W M Saunders, G T Chen, R D Stone.   

Abstract

Neovascular glaucoma developed in 22 of 169 uveal melanoma patients treated with helium ion irradiation. Most patients had large melanomas; no eyes containing small melanomas developed anterior segment neovascularization. The mean onset of glaucoma was 14.1 months (range, 7-31 months). The incidence of anterior segment neovascularization increased with radiation dosage; there was an approximately three-fold increase at 80 GyE versus 60 GyE of helium ion radiation (23% vs. 8.5%) (P less than 0.05). Neovascular glaucoma occurred more commonly in larger tumors; the incidence was not affected by tumor location, presence of subretinal fluid, nor rate of tumor regression. Fifty-three percent of patients had some response with intraocular pressures of 21 mmHg or less to a combination of antiglaucoma treatments.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419816     DOI: 10.1016/s0161-6420(86)33770-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Experimental study on the fractionation schedule for proton irradiation of uveal melanoma.

Authors:  G Wollensak; L Zografos; C Perret; E Egger; H Fritz-Niggli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Development and validation of a patient based measure of outcome in ocular melanoma.

Authors:  A J Foss; D L Lamping; S Schroter; J Hungerford
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

4.  Microwave plaque thermoradiotherapy for choroidal melanoma.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

5.  Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma.

Authors:  A J Foss; I Whelehan; J L Hungerford; D F Anderson; R D Errington; A Kacperek; M Restori; J Kongerud; M Sheen
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

6.  Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland.

Authors:  Samir Aziz; Alex Taylor; Andrzej McConnachie; Alex Kacperek; Ewan Kemp
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation.

Authors:  Chryssanthi Koutsandrea; Marilita M Moschos; Michael Dimissianos; Gerasimos Georgopoulos; Ioannnis Ladas; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2008-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.